Home Pilots Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development Pilots Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development By - September 1, 2022 54 0 Facebook Twitter Pinterest WhatsApp It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Rune Labs scores FDA 510(k) to monitor Parkinson’s symptoms on Apple Watch Pilots - June 14, 2022 0 Munich-based Wellster raises $60M to launch European femtech platform Pilots - January 24, 2022 0 GripAble raises $11M for gamified hand and arm rehab Pilots - April 12, 2022 0 How open source innovation can mitigate digital health inequities Pilots - March 17, 2022 0 Syra Health scores contract to assess racial, ethnic approaches to health in Texas Pilots - November 21, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3